Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Clin Cancer Res. 2015 Feb 27;21(12):2792–2801. doi: 10.1158/1078-0432.CCR-14-3279

Table 1.

Summary of dose modifying factors (DMFs), PF-05212384 (10μM) toxicity alone, and PF-05212384 impact on cell cycle distribution.

24 Hr Pre-XRT Treat 24 Hr Post-XRT Treat 24 Hour PF-384 (10μM) Exposure (No IR)
DMF (±SEM) DMF (±SEM) Surviving Fraction (±SEM) G1(%)* (Control G1%) S(%) (Control S%) G2/M(%) (Control G2/M%)
UMSCC1 1.9 (±.07) 3.6 (±.14) .71 (±.06) 88% (39%) 6% (56%) 6% (5%)
UMSCC46 1.0 (±.00) 1.9 (±.25) .84 (±.09) 45% (32%) 24% (43%) 31% (25%)
1522 1.0 (±.00) 1.4 (±.15) .84 (±.06) 81% (65%) 3% (21%) 17% (15%)
UMSCC1 (Plateau) 1.6 (±.05) 2.2 (±.55) .62 (±.03) 87% (69%) 7% (26%) 6% (5%)
*

Cell cycle distribution plots are shown in Supplementary Figure S2. Cell cycle distribution data representative of multiple experiments.